Cargando…
HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
BACKGROUND: Accompanied by HBV infection, HBV mutations gradually occur because HBV polymerase appears proofread deficiencies. In our previous study, we have identified that EnhII/BCP/PC mutations and genotype C of HBV DNA were associated with hepatocellular carcinoma (HCC) risk. In this study, we e...
Autores principales: | Ge, Zijun, Tian, Ting, Meng, Lijuan, Song, Ci, Yu, Chengxiao, Xu, Xin, Liu, Jibin, Dai, Juncheng, Hu, Zhibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558498/ https://www.ncbi.nlm.nih.gov/pubmed/31033235 http://dx.doi.org/10.1002/cam4.2169 |
Ejemplares similares
-
SOX2 Represses Hepatitis B Virus Replication by Binding to the Viral EnhII/Cp and Inhibiting the Promoter Activation
por: Yang, Hua, et al.
Publicado: (2020) -
Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma
por: Ma, Shijie, et al.
Publicado: (2017) -
Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma
por: Song, Ci, et al.
Publicado: (2016) -
Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection
por: Zhang, Xia, et al.
Publicado: (2016) -
T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)